- $263.73m
- $126.77m
- $158.71m
- 56
- 41
- 70
- 56
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 335 | 279 | 232 | 162 | 159 |
Cost of Revenue | |||||
Gross Profit | 308 | 258 | 210 | 145 | 143 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 396 | 297 | 265 | 287 | 215 |
Operating Profit | -60.9 | -18.5 | -33.5 | -126 | -56.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -59.7 | -19.8 | -38.2 | -121 | -49.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -58.3 | -19.8 | -38.4 | -119 | -49.8 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -54.9 | 76.5 | -38.3 | -119 | -49.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -54.9 | 76.5 | -38.3 | -119 | -49.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.48 | -0.084 | -0.383 | -0.863 | -0.483 |